Market Capitalization | 5.2M |
Book Value | $0.17 |
Earnings Per Share (EPS) | -1.99 |
Wall Street Target Price | 1.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -46.63% |
Return On Equity TTM | -185.31% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -121.0M |
Diluted Eps TTM | -1.99 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
A Spac I Acquisition Corp
$0.06
+0.0%
Gamida Cell Ltd
$0.06
+0.0%
Palladyne Ai Corp
$0.06
+0.0%
Keyarch Acquisition Corp
$0.06
+0.0%
Acorda Therapeutics, Inc.
$0.06
+0.0%
Connexa Sports Technologies Inc
$0.06
+0.0%
Semantix Inc
$0.06
+0.0%
Arrowroot Acquisition Corp-a
$0.06
+0.0%
Anfield Capital Diversified Alternatives Etf
$0.06
+0.0%